Australia's largest stock trading and investment forum Australia's #1 stock forum

SPL

Click for more information

0.00%

9.7¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-24

First 24 Last

Share
Profile

Follow
Domesticgod

1,790 Posts.

317

15/09/21

16:57

Post #: 56090549
Share

Originally posted by chrisnj ↑

Management have been spruiking about the viral conjunctivitis drops and "commercial discussions" since 2014.

A patent was granted in 2018.

Before anything else clinical trials need to be conducted which to me as a layman should be relatively straight forward.

So can someone please tell me why nothing has eventuated and please don't blame Covid-19

Here we have no approved therapies and an estimated market of AU $1billion annually

This question is a must for the AGM.

Expand

Have another look at this conjunctivitis study, released in June 21.

www.ncbi.nlm.nih.gov/pmc/articles/PMC8201124/

What caught my eye was this. According to Jeremy Paul et all:-

“Further development of astodrimer sodium as a topical antiviral therapy for adenoviral ocular infections is indicated.“

Not “Commercialisation”, but “Further development”. After how many years?!

I am sure some employees still think Starpharma is still a government research centre, funded for ever by the general public.

SPL Price at posting: $1.37 Sentiment: Hold Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 18 more messages in this thread...

First 24 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.7¢		Change 0.000(0.00%)		Mkt cap ! $40.00M

Open	High	Low	Value	Volume
9.8¢	10.5¢	9.6¢	$210.8K	2.098M

Buyers (Bids)

No.	Vol.	Price($)
1	30408	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.7¢	3523	2

View Market Depth

No.	Vol.	Price($)
1	30408	0.095
2	15638	0.094
3	83394	0.093
2	108435	0.091
2	41000	0.090

Price($)	Vol.	No.
0.097	3523	2
0.105	119848	4
0.110	114099	6
0.115	77331	6
0.120	89055	5

Last trade - 16.10pm 09/07/2024 (20 minute delay)

SPL (ASX) Chart